Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial
3 other identifiers
interventional
39
1 country
1
Brief Summary
This trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer. Tai Chi is a mind-body therapy that integrates moderate physical activity, deep breathing and meditation. Tai Chi may help to reduce aromatase inhibitor-induced joint pain, and offer a promising approach to managing symptoms in cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2020
CompletedFirst Submitted
Initial submission to the registry
December 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2021
CompletedApril 29, 2025
April 1, 2025
1.4 years
December 7, 2020
April 28, 2025
Conditions
Outcome Measures
Primary Outcomes (10)
Tai Chi practice
Diary log form.
Up to 12 weeks
Tai Chi practice
Examples include documenting potential issues that participants think might be intervention-related.
Up to 12 weeks
Assess the client's perspective on the value of services received
Will be assessed using the Client Satisfaction Questionnaire. Qualitatively, five questions, adapted from previous yoga research will be used in post-intervention patient interview.
Up to 36 weeks
Lower-extremity joint symptoms
Western Ontario and McMaster Universities Arthritis Index will be used to assess pain in the past 7 days in three domains: pain, stiffness, and physical function; higher scores indicating worse pain, stiffness, and functional limitations.
Up to 12 weeks
Pain, stiffness, and physical function in the hands
Australian/Canadian Osteoarthritis (OA) Hand Index will be used to assess pain, stiffness, and physical function in the hands.
Up to 12 weeks
Assess pain, pain severity, and pain interference
Brief Pain Inventory will be used to assess worst pain, pain severity, and pain interference over the past week.
up to 12 weeks
Fatigue
Fatigue Symptom Inventory will be used to measure change in fatigue among breast cancer (BCa) patients and with strong internal consistency.
Up to 12 weeks
Effects of Hot Flashes on Quality of life
Hot Flash Related Daily Interference Scale will be used to measure the effect of hot flashes on overall quality of life and on nine specific activities: work, social activities, leisure activities, sleep, mood, concentration, relations with others, sexuality, and enjoyment of life.
Up to 12 weeks
Assessment of Sleep quality
Pittsburg Sleep Quality Index will be used to for subjective sleep assessment, which includes multiple sleep-related variables over the preceding month.
Up to 12 weeks
Cancer-related distress
Centers for Epidemiologic Studies Depression Scale will be used to assess depressive symptoms.
Up to 12 weeks
Study Arms (1)
Supportive Care (Tai Chi, Fitbit, Tai4Chijoint group)
EXPERIMENTALPatients attend Tai Chi exercise classes over 1 hour BIW and wear a Fitbit device for up to 12 weeks. Patients are encouraged to complete self-practice over 30 minutes and record practice times daily in a diary log form. Patients also join a Facebook private TaiChi4joint group where they receive instructional videos matching the progress of weekly classes for at-home practices and peer support in Tai Chi engagement.
Interventions
Join Tai4Chijoint group
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- Be able to speak and read English
- Been diagnosed with stage I-III breast cancer (BC)
- Had completed all active treatments
- Had been receiving an AI (anastrozole, letrozole, or exemestane) for at least 3 months
- Had joint (knee, hand or hip) pain or stiffness that started or worsened after the initiation of AI
- Report worst pain in the past week \>= 4 on a 0-10 numeric rating scale
- Be willing to adhere to all study procedures
You may not qualify if:
- Has been diagnosed with another form of cancer in the past 5 years
- Uncontrolled cardiac, pulmonary, or infectious disease
- Body mass index (BMI) \> 40 kg/m\^2
- Currently attending any mind-body therapy classes (e.g. yoga)
- Joint pain due to inflammatory arthritic condition (such as rheumatoid arthritis, osteoarthritis or gout, which will be assessed during eligibility screening with patient self-reported data and will be screened through electronic medical record \[EMR\] data)
- Had surgery or joint infection in the past 6 months
- Currently taking corticosteroids or opioids, have discontinued or plan to discontinue AI in the next 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Jefferson Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
Related Publications (1)
Gomaa S, West C, Lopez AM, Zhan T, Schnoll M, Abu-Khalaf M, Newberg A, Wen KY. A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study. JMIR Form Res. 2022 Jun 21;6(6):e34995. doi: 10.2196/34995.
PMID: 35727609DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2020
First Posted
January 20, 2021
Study Start
March 11, 2020
Primary Completion
July 21, 2021
Study Completion
December 23, 2021
Last Updated
April 29, 2025
Record last verified: 2025-04